X-Chem, Inc., a provider of DNA-Encoded Library (DEL)-based discovery services, has acquired IntelliSyn, a Montreal-based drug discovery services company and its U.S.-based sister company, AviSyn. The acquisitions allow the Company to offer services for screening, hit validation and lead optimization on existing and new markets. Financial details were not disclosed.   Leveraging its DEX platform with libraries containing over 200 billion small molecules, X-Chem discovers new drug leads for bio...